Fast forward nearly 3 years since the first case of COVID-19 was reported, and I am amazed of the speed of response on how to keep our patients with rheumatic and musculoskeletal disease (RMD) safe…

Is there finally something new on the horizon in Sjogren’s syndrome?  At the second plenary session, Dr. Thomas Dorner presented abstract 1113 on a medication that may at long last be a disease…

The masses have returned to ACR22, a live, face-to-face, and virtual, meeting that began Saturday in Philadelphia. Throngs and gaggles of MSK wannabees crammed the ballrooms and rushed the exhibits…

The ability to prevent rheumatoid arthritis (RA) in individuals at risk of developing this condition is a holy grail in rheumatology. There is a long-history of interest in this area dating back to…

The RheumNow faculty reporters have been scouring the meeting and online presentations to find the best abstracts from ACR22. Here are some of their choice abstracts reported today on day 1 of…

It’s widely accepted that Psoriatic disease has multi-system, multi-domain potential that can lead to life altering complications if left untreated or undertreated. Because of this disease potential…

Women with systemic lupus erythematosus (SLE) face unique reproductive challenges including increased risk of thrombosis with estrogen-containing contraceptives, preeclampsia, pregnancy loss, and…

Rheumatoid arthritis is known to be associated with a higher risk of infections, and this occurs for multiple reasons: immune dysfunction, systemic inflammation, comorbidities, and treatments. While…

Systemic lupus erythematosus (SLE) is a chronic autoimmune condition and monitoring disease activity is an important aspect of disease management.  The anti-dsDNA antibody is highly specific for…

Today's plenary session features a novel proposal on how and which patients with Idiopathic Inflammatory Myopathy (IIM) should be screened for cancer.  Abstract 0002 by Oldroyd et al,…